90 related articles for article (PubMed ID: 21208810)
1. Serum VEGF levels and tissue activation of VEGFR2/KDR receptors in patients with breast and gynecologic cancer.
Koukourakis MI; Limberis V; Tentes I; Kontomanolis E; Kortsaris A; Sivridis E; Giatromanolaki A
Cytokine; 2011 Mar; 53(3):370-5. PubMed ID: 21208810
[TBL] [Abstract][Full Text] [Related]
2. Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.
Weigand M; Hantel P; Kreienberg R; Waltenberger J
Angiogenesis; 2005; 8(3):197-204. PubMed ID: 16328160
[TBL] [Abstract][Full Text] [Related]
3. Tumor specific VEGF-A and VEGFR2/KDR protein are co-expressed in breast cancer.
Rydén L; Linderholm B; Nielsen NH; Emdin S; Jönsson PE; Landberg G
Breast Cancer Res Treat; 2003 Dec; 82(3):147-54. PubMed ID: 14703061
[TBL] [Abstract][Full Text] [Related]
4. [Expression of vascular endothelial growth factor and its receptor Flk-1/KDR in benign and malignant breast neoplasms].
Li YJ; Wen G; Wang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):70-1, 74. PubMed ID: 19218116
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of expression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage I non-small-cell lung cancer.
Seto T; Higashiyama M; Funai H; Imamura F; Uematsu K; Seki N; Eguchi K; Yamanaka T; Ichinose Y
Lung Cancer; 2006 Jul; 53(1):91-6. PubMed ID: 16697074
[TBL] [Abstract][Full Text] [Related]
6. Soluble urokinase plasminogen activator receptor in preoperatively obtained plasma from patients with gynecological cancer or benign gynecological diseases.
Riisbro R; Stephens RW; Brünner N; Christensen IJ; Nielsen HJ; Heilmann L; von Tempelhoff GF
Gynecol Oncol; 2001 Sep; 82(3):523-31. PubMed ID: 11520150
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 expression in non-small cell lung cancer patients: relation to prognosis.
Bonnesen B; Pappot H; Holmstav J; Skov BG
Lung Cancer; 2009 Dec; 66(3):314-8. PubMed ID: 19324448
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor (VEGF) and ovarian carcinoma cell supernatant activate signal transducers and activators of transcription (STATs) via VEGF receptor-2 (KDR) in human hemopoietic progenitor cells.
Ye F; Chen HZ; Xie X; Ye DF; Lu WG; Ding ZM
Gynecol Oncol; 2004 Jul; 94(1):125-33. PubMed ID: 15262130
[TBL] [Abstract][Full Text] [Related]
9. An autocrine VEGF/VEGFR2 and p38 signaling loop confers resistance to 4-hydroxytamoxifen in MCF-7 breast cancer cells.
Aesoy R; Sanchez BC; Norum JH; Lewensohn R; Viktorsson K; Linderholm B
Mol Cancer Res; 2008 Oct; 6(10):1630-8. PubMed ID: 18922978
[TBL] [Abstract][Full Text] [Related]
10. [Vascular endothelial growth factor and two types of its receptors in breast cancer].
Shcherbakov AM; Gershteĭn ES; Anurova OA; Kushlinskiĭ NE
Vopr Onkol; 2005; 51(3):317-21. PubMed ID: 16279095
[TBL] [Abstract][Full Text] [Related]
11. Activated VEGFR2/KDR pathway in tumour cells and tumour associated vessels of colorectal cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Chlouverakis G; Vourvouhaki E; Turley H; Harris AL; Gatter KC
Eur J Clin Invest; 2007 Nov; 37(11):878-86. PubMed ID: 17883421
[TBL] [Abstract][Full Text] [Related]
12. Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis.
Giatromanolaki A; Sivridis E; Gatter KC; Turley H; Harris AL; Koukourakis MI;
Gynecol Oncol; 2006 Dec; 103(3):912-8. PubMed ID: 16837029
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
Mele T; Generali D; Fox S; Brizzi MP; Bersiga A; Milani M; Allevi G; Bonardi S; Aguggini S; Volante M; Dogliotti L; Bottini A; Harris A; Berruti A
Breast Cancer Res Treat; 2010 Oct; 123(3):795-804. PubMed ID: 20680681
[TBL] [Abstract][Full Text] [Related]
14. Comparison of serum VEGF and its soluble receptor sVEGFR1 with serum cell-free DNA in patients with breast tumor.
El Tarhouny S; Seefeld M; Fan AX; Hahn S; Holzgreve W; Zhong XY
Cytokine; 2008 Oct; 44(1):65-9. PubMed ID: 18691902
[TBL] [Abstract][Full Text] [Related]
15. Glucose is a key regulator of VEGFR2/KDR in human epithelial ovarian carcinoma cells.
Adham SA; Coomber BL
Biochem Biophys Res Commun; 2009 Dec; 390(1):130-5. PubMed ID: 19782046
[TBL] [Abstract][Full Text] [Related]
16. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific expression of vascular endothelial growth factor receptor 2 but not vascular endothelial growth factor or human epidermal growth factor receptor 2 is associated with impaired response to adjuvant tamoxifen in premenopausal breast cancer.
Rydén L; Jirström K; Bendahl PO; Fernö M; Nordenskjöld B; Stål O; Thorstenson S; Jönsson PE; Landberg G
J Clin Oncol; 2005 Jul; 23(21):4695-704. PubMed ID: 16034044
[TBL] [Abstract][Full Text] [Related]
18. Bronchial washing levels of vascular endothelial growth factor receptor-2 (VEGFR2) correlate with overall survival in NSCLC patients.
Charpidou A; Gkiozos I; Konstantinou M; Eleftheraki A; Demertzis P; Harrington K; Polyzos A; Syrigos KN
Cancer Lett; 2011 May; 304(2):144-53. PubMed ID: 21396771
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of serum vascular endothelial growth factor in Egyptian females with metastatic triple negative breast cancer.
Taha FM; Zeeneldin AA; Helal AM; Gaber AA; Sallam YA; Ramadan H; Moneer MM
Clin Biochem; 2009 Sep; 42(13-14):1420-6. PubMed ID: 19576877
[TBL] [Abstract][Full Text] [Related]
20. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
